Syncom Formulations (India) Limited (BOM:524470)

India flag India · Delayed Price · Currency is INR
18.27
+0.65 (3.69%)
At close: Jul 29, 2025
3.69%
Market Cap17.17B
Revenue (ttm)4.65B
Net Income (ttm)494.35M
Shares Out940.00M
EPS (ttm)0.57
PE Ratio32.05
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume296,165
Average Volume230,943
Open17.50
Previous Close17.62
Day's Range17.30 - 18.50
52-Week Range14.10 - 27.94
Beta1.06
RSI41.66
Earnings DateAug 11, 2025

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of comm... [Read more]

Industry Pharmaceutical Preparations
Founded 1988
Employees 998
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524470
Full Company Profile

Financial Performance

In 2024, BOM:524470's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.

Financial Statements

News

There is no news available yet.